Tetrasodium EDTA disrupts Pseudomonas aeruginosa membrane integrity, shows suppressed resistance evolution and reduced cytotoxicity compared to meropenem
Authors:
- Oluwatosin Qawiyy OrababaOOOluwatosin Qawiyy Orababa
- Charlotte CornbillCCCharlotte Cornbill
- Ayomikun KadeAKAyomikun Kade
- Chidiebere F. UchechukwuCUChidiebere F. Uchechukwu
- Shristi SharmaShristi Sharma
- Leonard UzaiureLeonard Uzaiure
- Natasha ReddyNRNatasha Reddy
- Rupika GulatiRGRupika Gulati
- Blessing OyedemiBOBlessing Oyedemi
- Freya HarrisonFHFreya Harrison
Preprint
Abstract
Pseudomonas aeruginosa remains one of the most important clinical pathogens for which new drugs are needed, due to its resistance machinery. Consequently, there is an increasing effort to develop new and effective treatments against this pathogen. We recently showed that tetrasodium ethylenediaminetetraacetic acid (tEDTA) exhibits promising antibacterial and antibiofilm activity against P. aeruginosa in advanced biofilm models. tEDTA is known to chelate divalent cations, with predicted effects on the outer membrane; however, a full understanding of how this kills P. aeruginosa is lacking. Also, it is currently not clear how slowly or rapidly P. aeruginosa will evolve resistance to this treatment. Using membrane disruption assays and RNA-seq, we showed that tEDTA disrupts bacterial membrane potential and permeabilises P. aeruginosa membranes. RNA-seq revealed the significant upregulation of genes involved in the transport of iron, phosphate, potassium, and magnesium ion. The arnABCD operon which is involved in lipid A biosynthesis was also upregulated. Using a 7-day evolutionary ramp approach, we showed that P. aeruginosa could not evolve resistance to tEDTA under strong selection. Lastly, we carried out a cytotoxicity assay with Human Epithelial type 2 (HEp-2) cells and showed that there was reduced cytotoxicity of tEDTA compared to meropenem. This study provides good insight into the mechanism of action of tEDTA and further evidence of its potential as an alternative to antibiotics for P. aeruginosa infections.Keywords
Funding Information
- Biotechnology and Biological Sciences Research Council (BB/T00746X/1)
- University of Warwick, Institute of Advanced Studies IRDA & School of Life Sciences Pump priming award
This publication has 33 references indexed in Scilit:
- Role of Divalent Ions in Membrane Models of Polymyxin-Sensitive and Resistant Gram-Negative BacteriaJournal of Chemical Information and Modeling, 2025
- Antivirulence therapy: type IV pilus as a druggable target for bacterial infectionsMedicinal Chemistry Research, 2024
- Roles of Pseudomonas aeruginosa siderophores in interaction with prokaryotic and eukaryotic organismsResearch in Microbiology, 2024
- Pseudomonas aeruginosa: Infections and novel approaches to treatment “Knowing the enemy” the threat of Pseudomonas aeruginosa and exploring novel approaches to treatmentInfectious Medicine, 2023
- The Microbiologist’s Guide to Membrane Potential DynamicsTrends in Microbiology, 2020
- Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategiesBiotechnology Advances, 2019
- The Efficacy of Tetrasodium EDTA on Biofilms2017
- Effect of Divalent Cation Removal on the Structure of Gram-Negative Bacterial Outer Membrane ModelsLangmuir, 2014
- Fast gapped-read alignment with Bowtie 2Nature Methods, 2012
- Ion modulation of membrane permeability: Effect of cations on intact cells and on cells and phospholipid bilayers treated with pore-forming agentsThe Journal of Membrane Biology, 1988